Randomized Trial of Avelumab-cetuximab-radiotherapy Versus SOCs in LA SCCHN (REACH)

NCT02999087 · clinicaltrials.gov ↗

PHASE3

Phase

ACTIVE_NOT_RECRUITING

Status

707

Enrollment

OTHER

Sponsor class

Conditions

HNSCC

Interventions

DRUG: Cetuximab
DRUG: avelumab
DRUG: Cisplatin
RADIATION: IMRT

Sponsor

Groupe Oncologie Radiotherapie Tete et Cou

Collaborators

[object Object]